1. Selective TASK-1 Inhibitor with a Defined Structure–Activity Relationship Reduces Cancer Cell Proliferation and Viability
   Bárbara Arévalo et al, 2022, Journal of Medicinal Chemistry CrossRef
2. Potassium Channels as a Target for Cancer Therapy: Current Perspectives
   Leandro Zúñiga et al, 2022, OncoTargets and Therapy CrossRef